Search research articles
Contact Us
Filters
Showing results (121-130 of 182) with videos related to
Page
of 19
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
July 24, 2018
Associations of anticoagulant use with outcome in newly diagnosed glioblastoma
Emilie Le Rhun, Els Genbrugge, Roger Stupp, et al.
Statistics in Medicine
|
January 8, 2011
Multiple imputation of missing dual-energy X-ray absorptiometry data in the National Health and Nutrition Examination Survey
Nathaniel Schenker, Lori G Borrud, Vicki L Burt, et al.
Journal of Neuro-Oncology
|
April 20, 2022
High-dose methotrexate and rituximab induction regimen in immunocompetent patients with primary CNS lymphoma: a retrospective single-center study of survival predictors
Andrew B DeAtkine, Moaaz Abdelrashid, Zach Tucker, et al.
Journal of Neuro-Oncology
|
March 10, 2010
Phase 1 clinical trial of bortezomib in adults with recurrent malignant glioma
Surasak Phuphanich, Jeffrey G Supko, Kathryn A Carson, et al.
Journal of Neuro-Oncology
|
October 20, 2021
Mitochondrial DNA sequence variation and risk of meningioma
Claudine M Samanic, Jamie K Teer, Zachary J Thompson, et al.
Journal of Neuro-Oncology
|
March 26, 2013
Mutant tristetraprolin: a potent inhibitor of malignant glioma cell growth
Esther A Suswam, John J Shacka, Kiera Walker, et al.
Vital and Health Statistics. Series 2, Data Evaluation and Methods Research
|
August 5, 2014
National Health and Nutrition Examination Survey: sample design, 2007-2010
Lester R Curtin, Leyla K Mohadjer, Sylvia M Dohrmann, et al.
Neuro-Oncology
|
January 19, 2013
NABTT 0502: a phase II and pharmacokinetic study of erlotinib and sorafenib for patients with progressive or recurrent glioblastoma multiforme
David M Peereboom, Manmeet S Ahluwalia, Xiaobu Ye, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 6, 2018
<i>MGMT</i> Promoter Methylation Cutoff with Safety Margin for Selecting Glioblastoma Patients into Trials Omitting Temozolomide: A Pooled Analysis of Four Clinical Trials
Monika E Hegi, Els Genbrugge, Thierry Gorlia, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
July 21, 2022
Inhibition of the RNA Regulator HuR by SRI-42127 Attenuates Neuropathic Pain After Nerve Injury Through Suppression of Neuroinflammatory Responses
Robert E Sorge, Ying Si, Lyse A Norian, et al.
Page
of 19
Search research articles
Search
Showing results (121-130 of 182) with videos related to
Sort By:
Page
of 19
European Journal of Cancer (Oxford, England : 1990)
|
July 24, 2018
Associations of anticoagulant use with outcome in newly diagnosed glioblastoma
Emilie Le Rhun, Els Genbrugge, Roger Stupp, et al.
Statistics in Medicine
|
January 8, 2011
Multiple imputation of missing dual-energy X-ray absorptiometry data in the National Health and Nutrition Examination Survey
Nathaniel Schenker, Lori G Borrud, Vicki L Burt, et al.
Journal of Neuro-Oncology
|
April 20, 2022
High-dose methotrexate and rituximab induction regimen in immunocompetent patients with primary CNS lymphoma: a retrospective single-center study of survival predictors
Andrew B DeAtkine, Moaaz Abdelrashid, Zach Tucker, et al.
Journal of Neuro-Oncology
|
March 10, 2010
Phase 1 clinical trial of bortezomib in adults with recurrent malignant glioma
Surasak Phuphanich, Jeffrey G Supko, Kathryn A Carson, et al.
Journal of Neuro-Oncology
|
October 20, 2021
Mitochondrial DNA sequence variation and risk of meningioma
Claudine M Samanic, Jamie K Teer, Zachary J Thompson, et al.
Journal of Neuro-Oncology
|
March 26, 2013
Mutant tristetraprolin: a potent inhibitor of malignant glioma cell growth
Esther A Suswam, John J Shacka, Kiera Walker, et al.
Vital and Health Statistics. Series 2, Data Evaluation and Methods Research
|
August 5, 2014
National Health and Nutrition Examination Survey: sample design, 2007-2010
Lester R Curtin, Leyla K Mohadjer, Sylvia M Dohrmann, et al.
Neuro-Oncology
|
January 19, 2013
NABTT 0502: a phase II and pharmacokinetic study of erlotinib and sorafenib for patients with progressive or recurrent glioblastoma multiforme
David M Peereboom, Manmeet S Ahluwalia, Xiaobu Ye, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 6, 2018
<i>MGMT</i> Promoter Methylation Cutoff with Safety Margin for Selecting Glioblastoma Patients into Trials Omitting Temozolomide: A Pooled Analysis of Four Clinical Trials
Monika E Hegi, Els Genbrugge, Thierry Gorlia, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
July 21, 2022
Inhibition of the RNA Regulator HuR by SRI-42127 Attenuates Neuropathic Pain After Nerve Injury Through Suppression of Neuroinflammatory Responses
Robert E Sorge, Ying Si, Lyse A Norian, et al.
Page
of 19